Early research (Phase 1)Study completedNCT04451954
What this trial is testing
Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects
Who this might be right for
Influenza ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 210